Dr. Sunilkumar K. Kakadia, MD

Dr. Kakadia practices at Genesis Cancer and Blood Institute Higdon Ferry - HOPD in Hot Springs National Park, Arkansas.

Dr. Kakadia's NPI, 1689921017, was assigned on August 3, 2012. Dr. Kakadia holds Arkansas license E-10851.

Dr. Kakadia's primary practice is Genesis Cancer and Blood Institute Higdon Ferry - HOPD, at 1455 Higdon Ferry Rd, Hot Springs National Park, AR 71913.

Dr. Kakadia's primary practice is Genesis Cancer and Blood Institute Higdon Ferry - HOPD in Hot Springs National Park, Arkansas. Dr. Kakadia is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Kakadia to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kakadia practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kakadia's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kakadia is licensed in Arkansas.

CMS data shows 97,205 Medicare services from Dr. Kakadia across 42 procedure codes in 2024, for 549 Medicare patients. Medicare paid $1,813,456 for them.

CMS counts 549 Medicare patients who saw Dr. Kakadia in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kakadia's median patient age at 73, with 46% women.

In 2024, Dr. Kakadia wrote 1,263 Medicare Part D claims for 198 patients. 72% of them were for generic drugs. CMS names the drug for 911 of them, across 33 drugs with 11 or more claims each, at $1,743,488 in total drug cost. In 2023, CMS named 524 claims across 21 drugs.

Dr. Kakadia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Kakadia, published from 2018 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Hematopoietic Stem Cell Transplantation. Dr. Kakadia has published most often in Eur J Case Rep Intern Med. Dr. Kakadia's most frequent co-authors are Naveen Kumar Yarlagadda, MD, Daisy V. Alapat, MD and Samer Ahmad Suleiman Al Hadidi, MD.

CMS Open Payments shows 427 general payments to Dr. Kakadia from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,861.